Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Current assets
Cash	$ 4,022,453	$ 6,611,928
Accounts receivable, net of allowance for bad debt of $79,465 and $60,012	1,196,654	1,285,165
Royalty receivable	49,344	50,250
Inventory, net of allowance for obsolescence of $58,574 and $43,650	1,009,213	746,519
Prepaid other - related party	200,000	0
Prepaid and other assets	311,852	161,902
Total current assets	6,789,516	8,855,764
Long-term assets
Property, plant and equipment, net of accumulated depreciation of $75,754 and $60,694	245,402	204,953
Right of use assets - operating leases	556,533	585,251
Intangible assets, net of accumulated amortization of $641,323 and $603,580	1,933,452	1,471,194
Total long-term assets	2,735,387	2,261,398
Total assets	9,524,903	11,117,162
Current liabilities
Accounts payable	289,505	337,504
Accounts payable - related party	206,849	68,668
Accrued royalties and expenses	675,442	528,060
Accrued bonus and commissions	1,225,486	1,588,056
Operating lease liability - current	120,121	117,533
Total current liabilities	2,517,403	2,639,821
Long-term liabilities
Operating lease liability - long term	450,461	481,384
Convertible notes payable - related party	0	1,500,000
Accrued interest - related party	0	103,557
Total long-term liabilities	450,461	2,084,941
Total liabilities	2,967,864	4,724,762
Shareholders' equity (deficit)
Series F Convertible Preferred Stock: $10 par value, 1,200,000 shares authorized; none issued and outstanding as of March 31, 2020 and 1,136,815 issued and outstanding as of December 31, 2019	0	11,368,150
Common Stock: $0.001 par value, 20,000,000 shares authorized; 6,203,832 issued and outstanding as of March 31, 2020 and 3,571,001 issued and outstanding as of December 31, 2019	6,204	3,571
Additional paid-in capital	11,289,339	(2,081,829)
Accumulated deficit	(4,512,759)	(2,675,802)
Total Sanara MedTech shareholders' equity (deficit)	6,782,784	6,614,090
Equity attributable to noncontrolling interest	(225,745)	(221,690)
Total shareholders' equity (deficit)	6,557,039	6,392,400
Total liabilities and shareholders' equity	$ 9,524,903	$ 11,117,162